Chiang, Ying-Cheng <br/><br/>
Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients.  [electronic resource] 

 -  Endocrine-related cancer  Apr 2013 
 - 213-27 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1479-6821 
<br/><br/><label>Standard No.: </label>10.1530/ERC-12-0117  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis<br/>Biomarkers, Tumor<br/>Carcinoma, Ovarian Epithelial<br/>Cell Line, Tumor<br/>Cisplatin--pharmacology<br/>Cytoskeletal Proteins<br/>Drug Resistance, Neoplasm<br/>Epigenomics<br/>Female<br/>Gene Silencing<br/>Humans<br/>Methylation<br/>Neoplasms, Glandular and Epithelial--genetics<br/>Ovarian Neoplasms--genetics<br/>Paclitaxel--pharmacology<br/>Prognosis<br/>RNA, Small Interfering--genetics<br/>Tumor Suppressor Proteins--genetics